288 related articles for article (PubMed ID: 33767386)
21. Low incidence of SNVs and indels in trio genomes of Cas9-mediated multiplex edited sheep.
Wang X; Liu J; Niu Y; Li Y; Zhou S; Li C; Ma B; Kou Q; Petersen B; Sonstegard T; Huang X; Jiang Y; Chen Y
BMC Genomics; 2018 May; 19(1):397. PubMed ID: 29801435
[TBL] [Abstract][Full Text] [Related]
22. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
Alrafiah AR
In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
[TBL] [Abstract][Full Text] [Related]
23. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
24. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.
Ferraiuolo L; Meyer K; Sherwood TW; Vick J; Likhite S; Frakes A; Miranda CJ; Braun L; Heath PR; Pineda R; Beattie CE; Shaw PJ; Askwith CC; McTigue D; Kaspar BK
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6496-E6505. PubMed ID: 27688759
[TBL] [Abstract][Full Text] [Related]
25. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis.
Sangwan S; Eisenberg DS
Postepy Biochem; 2016; 62(3):362-369. PubMed ID: 28132491
[TBL] [Abstract][Full Text] [Related]
26. Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing.
Guo T; Feng YL; Xiao JJ; Liu Q; Sun XN; Xiang JF; Kong N; Liu SC; Chen GQ; Wang Y; Dong MM; Cai Z; Lin H; Cai XJ; Xie AY
Genome Biol; 2018 Oct; 19(1):170. PubMed ID: 30340517
[TBL] [Abstract][Full Text] [Related]
27. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.
Ayers JI; Diamond J; Sari A; Fromholt S; Galaleldeen A; Ostrow LW; Glass JD; Hart PJ; Borchelt DR
Acta Neuropathol; 2016 Dec; 132(6):827-840. PubMed ID: 27704280
[TBL] [Abstract][Full Text] [Related]
28. Molecular dissection of ALS-associated toxicity of SOD1 in transgenic mice using an exon-fusion approach.
Deng HX; Jiang H; Fu R; Zhai H; Shi Y; Liu E; Hirano M; Dal Canto MC; Siddique T
Hum Mol Genet; 2008 Aug; 17(15):2310-9. PubMed ID: 18424447
[TBL] [Abstract][Full Text] [Related]
29. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
[TBL] [Abstract][Full Text] [Related]
30. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Gento-Caro Á; Vilches-Herrando E; Portillo F; González-Forero D; Moreno-López B
Brain Pathol; 2022 May; 32(3):e13022. PubMed ID: 34585475
[TBL] [Abstract][Full Text] [Related]
31. Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review.
Long C; Amoasii L; Bassel-Duby R; Olson EN
JAMA Neurol; 2016 Nov; 73(11):1349-1355. PubMed ID: 27668807
[TBL] [Abstract][Full Text] [Related]
32. Efficient CRISPR/Cas9-based gene knockout in watermelon.
Tian S; Jiang L; Gao Q; Zhang J; Zong M; Zhang H; Ren Y; Guo S; Gong G; Liu F; Xu Y
Plant Cell Rep; 2017 Mar; 36(3):399-406. PubMed ID: 27995308
[TBL] [Abstract][Full Text] [Related]
33. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
34. A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis.
Deneault E; Chaineau M; Nicouleau M; Castellanos Montiel MJ; Franco Flores AK; Haghi G; Chen CX; Abdian N; Shlaifer I; Beitel LK; Durcan TM
Methods; 2022 Jul; 203():297-310. PubMed ID: 34500068
[TBL] [Abstract][Full Text] [Related]
35. Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1
Orienti I; Armida M; Dobrowolny G; Pepponi R; Sollazzini G; Pezzola A; Casola I; Musarò A; Popoli P; Potenza RL
Neuroscience; 2021 Oct; 473():1-12. PubMed ID: 34363869
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
37. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
Shibata N
Neuropathology; 2001 Mar; 21(1):82-92. PubMed ID: 11304046
[TBL] [Abstract][Full Text] [Related]
38. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
[TBL] [Abstract][Full Text] [Related]
39. ALS-associated mutation SOD1
Wang H; Yi J; Li X; Xiao Y; Dhakal K; Zhou J
Bone; 2018 Jan; 106():126-138. PubMed ID: 29030231
[TBL] [Abstract][Full Text] [Related]
40. Genome Editing by CRISPR/Cas9 in Sorghum Through Biolistic Bombardment.
Liu G; Li J; Godwin ID
Methods Mol Biol; 2019; 1931():169-183. PubMed ID: 30652290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
